Apo-Erlotinib 150 mg (Erlotinib (Erlotinib Hydrochloride) TABLET) 150 MG

APO-Erlotinib 150 mg tablets are a medication used to treat certain types of cancer. This oral tablet contains erlotinib hydrochloride, a tyrosine kinase inhibitor. Learn more about its uses and effects.

Strength

150 MG

Pack Size

30/100/500

Manufacturer / TM Owner

APOTEX INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

APO-Erlotinib 150 mg tablets are primarily used in the treatment of specific types of cancer. Erlotinib is a tyrosine kinase inhibitor that works by targeting certain proteins involved in cancer cell growth. It is often prescribed for conditions where these proteins are overactive, contributing to the proliferation of cancer cells. Patients may wonder, 'What is erlotinib used for?' This medication is typically used in the management of non-small cell lung cancer and pancreatic cancer, among other indications.

Side Effects

Common effects of APO-Erlotinib 150 mg tablets may include skin rash, diarrhea, and fatigue. Some individuals may experience appetite loss or nausea. These effects can vary in severity and duration. It is important to monitor any persistent or severe symptoms and consult a healthcare provider if necessary.

Precautions & Warnings

APO-Erlotinib 150 mg tablets should be handled with care. Store the medication in a cool, dry place away from direct sunlight. Keep the tablets out of reach of children and pets. Always follow the prescribed dosage and administration instructions provided by your healthcare provider.

Avoid Interactions

APO-Erlotinib 150 mg tablets may interact with certain medications, including those that are metabolized by the liver's cytochrome P450 enzymes. Alcohol and other substances that affect liver function may also interact with erlotinib. It is important to inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.

Frequently Asked Questions

APO-Erlotinib 150 mg tablets are used in the treatment of certain types of cancer, including non-small cell lung cancer and pancreatic cancer.

Store APO-Erlotinib 150 mg tablets in a cool, dry place away from direct sunlight and keep them out of reach of children and pets.

Common side effects may include skin rash, diarrhea, fatigue, appetite loss, and nausea.

APO-Erlotinib 150 mg may interact with other medications, so it is important to consult your healthcare provider before taking it with other drugs.

If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.